cost-effectiveness ratio of less than $500 per reducedquality day avoided, while the strategy of collecting washings and brushings has a marginal cost-effective¬ ness ratio greater than $500 per reduced-quality day avoided. However, if the cost of cytologic study falls to less than $30 per specimen, the marginal cost-effec¬ tiveness ratio of collecting brushings and washings falls to less than $500/reduced-qualityday avoided, and may be the most cost-effective strategy. Alternatively, if the cost of cytology specimens is greater than $250, then the marginal cost-effectiveness of collecting any cyto¬ logic specimen is more than $500 per reduced-quality day avoided.
The decision model is extremely sensitive to varia¬ tions in the marginal sensitivity of additional cytology.
In our base-case analysis, addition of one cytology specimen increases the sensitivity of bronchoscopy by 4%, from 80.8 to 84.8%, and has a marginal costeffectiveness ratio of $308 per reduced-quality day avoided. Addition of a second cytology specimen increases the sensitivity of bronchoscopy by only 0.5%, but increases the marginal cost-effectiveness ratio to $5,500 per reduced-quality day avoided. Sensitivity analysis indicates that if we use $500 as our threshold for the value of a single reduced-quality day avoided, then cytology becomes "worth it" if it increases the sensitivity of bronchoscopy by 3%. Likewise if collec¬ tion of any cytology specimen adds less than 3% sen¬ sitivity to bronchoscopy, the marginal cost-effective¬ ness of collecting that specimen is greater than $500 and may not be considered cost-effective. 
